Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE; INJECTION | 1200MG/20ML | 0 | TECENTRIQ | ATEZOLIZUMAB |
FDA Submissions
TYPE 9- BLA; Type 9 - New indication submitted as distinct BLA, consolidated | ORIG | 1 | AP | 2016-10-18 | PRIORITY |
Submissions Property Types
CDER Filings
GENENTECH INC
cder:Array
(
[0] => Array
(
[ApplNo] => 761041
[companyName] => GENENTECH INC
[docInserts] => ["Medication Guide","http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/ucm530718.pdf"]
[products] => [{"drugName":"TECENTRIQ","activeIngredients":"ATEZOLIZUMAB","strength":"1200MG\/20ML","dosageForm":"INJECTABLE; INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/18\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/761041s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"10\/18\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/761041s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/761041Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2016\\\/761041Orig1_toc.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2016\\\/761041Orig1s000SumR.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2016-10-18
)
)